1261569-85-0 Usage
Uses
Used in Pharmaceutical Industry:
(8aS)-octahydro-8a-Methyl-Pyrrolo[1,2-a]pyrazine is used as a building block for the synthesis of various drugs and pharmaceuticals due to its unique 3D structure and specific chemical properties. It plays a crucial role in medicinal chemistry, drug design, and chemical synthesis, contributing to the development of new therapeutic agents.
Used in Medicinal Chemistry:
(8aS)-octahydro-8a-Methyl-Pyrrolo[1,2-a]pyrazine is utilized as a key component in the design and synthesis of novel compounds with potential therapeutic effects. Its unique structure and properties allow for the creation of molecules with specific binding affinities and selectivity, enhancing the effectiveness of drugs targeting various diseases.
Used in Drug Design:
As a heterocyclic organic molecule, (8aS)-octahydro-8a-Methyl-Pyrrolo[1,2-a]pyrazine is employed in drug design to create molecules with desired pharmacological properties. Its incorporation into drug candidates can lead to improved potency, selectivity, and pharmacokinetic profiles, ultimately resulting in more effective treatments.
Used in Chemical Synthesis:
(8aS)-octahydro-8a-Methyl-Pyrrolo[1,2-a]pyrazine serves as a versatile intermediate in chemical synthesis, enabling the production of a wide range of compounds with diverse applications. Its reactivity and structural features facilitate the synthesis of complex molecules, expanding the scope of chemical research and development.
Potential Applications in Biological Research:
(8aS)-octahydro-8a-Methyl-Pyrrolo[1,2-a]pyrazine may possess biological activities and therapeutic effects that warrant further exploration. Its potential use in biological research could lead to the discovery of new mechanisms of action, opening up new avenues for the treatment of various diseases and conditions.
Check Digit Verification of cas no
The CAS Registry Mumber 1261569-85-0 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,6,1,5,6 and 9 respectively; the second part has 2 digits, 8 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 1261569-85:
(9*1)+(8*2)+(7*6)+(6*1)+(5*5)+(4*6)+(3*9)+(2*8)+(1*5)=170
170 % 10 = 0
So 1261569-85-0 is a valid CAS Registry Number.
1261569-85-0Relevant articles and documents
1 -(CYCLOPENT-2-EN-1 -YL)-3-(2-HYDROXY-3-(ARYLSULFONYL)PHENYL)UREA DERIVATIVES AS CXCR2 INHIBITORS
-
, (2015/12/18)
The invention relates to 1-(3-sulfonylphenyl)-3-(cyclopent-2-en-1-yl)urea derivatives, and their use in treating or preventing diseases and conditions mediated by the CXCR2 receptor. In addition, the invention relates to compositions containing the derivatives and processes for their preparation.
Design, synthesis, and structure-activity relationship study of bicyclic piperazine analogs of indole-3-carboxamides as novel cannabinoid CB1 receptor agonists
Moir, Elizabeth M.,Yoshiizumi, Kazuya,Cairns, Jim,Cowley, Phillip,Ferguson, Morag,Jeremiah, Fiona,Kiyoi, Takao,Morphy, Richard,Tierney, Jason,Wishart, Grant,York, Mark,Baker, James,Cottney, Jean E.,Houghton, Andrea K.,McPhail, Petula,Osprey, Andrew,Walker, Glenn,Adam, Julia M.
scheme or table, p. 7327 - 7330 (2011/01/12)
Bicyclic piperazine derivatives were synthesized as conformationally constrained analogs of N-alkyl piperazines and were found to be potent CB1 receptor agonists. The CB1 receptor agonist activity was dependent upon the absolute configuration of the chiral center of the bicyclic ring system. Although the conformational constraint did not protect the compounds from metabolism by N-dealkylation, several bicyclic analogs were found to be more potent than the unconstrained lead compound. Compound 8b demonstrated potent antinociceptive activity in vivo.
